Eloxx Pharmaceuticals, Inc. engages in the development of novel ribonucleic acid-modulating drug candidates. The firm focuses on the the formulation of medicines to treat rare and ultra-rare premature stop codon diseases. Its lead product candidate is ELX-02, a small molecule drug designed to restore production of full-length functional proteins. It operates through the United States and Israel geographical segments. The company was founded by Silvia Noiman on December 19, 2017 and is headquartered in Watertown, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A
Frequently Asked Questions
What is Market Cap of Eloxx Pharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Eloxx Pharmaceuticals Inc market cap is $0.00.
What is the 52-week high for Eloxx Pharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Eloxx Pharmaceuticals Inc 52 week high is $0.7501 as of October 10, 2025.
What is the 52-week low for Eloxx Pharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Eloxx Pharmaceuticals Inc 52 week low is $0.00 as of October 10, 2025.
What was Eloxx Pharmaceuticals Inc stock price yesterday?
Eloxx Pharmaceuticals Inc stock price yesterday was $0.0001.
What is the 50-day moving average of Eloxx Pharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Eloxx Pharmaceuticals Inc 50-day moving average is $0.0001.